Joe Biden’s Big Lead on Health Care Issues October 21, 2020 Perspective In an Axios column, Drew Altman discusses how this election year health isn’t a single issue — but several — and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.
Want to protect people with preexisting conditions? You need the full Affordable Care Act. October 22, 2020 Perspective In this perspective published by the Washington Post, KFF Executive Vice President for Health Policy Larry Levitt explains why the popular Affordable Care Act provisions that ensure people with pre-existing conditions can access affordable health insurance can’t easily be preserved if other related provisions are overturned.
Joe Biden’s New Health Care Agenda (and CMS’s Big Role In It) January 11, 2021 Perspective With the Georgia runoff elections giving Democrats control of the U.S. Senate, Drew Altman discusses President-elect Biden’s potential health care agenda and suggests that the Centers for Medicare & Medicaid Services could have an expanded role and that it may be time to rename it and elevate it to a cabinet agency.
The Inequity Of The Medicaid Coverage Gap and Why It Is Hard To Fix It October 14, 2021 Perspective In this column for the JAMA Health Forum, Larry Levitt explores why the Medicaid “coverage gap” still exists in 12 states that have not expanded their Medicaid programs under the Affordable Care Act, why it matters, and why eliminating it could prove challenging.
The Biggest Health Care Reform in a Decade Could Lower Your Costs August 13, 2022 Perspective Larry Levitt writes about the political and practical impact of the health care provisions in the Inflation Reduction Act in The New York Times guest essay, “The Biggest Health Care Reform in a Decade Could Lower Your Costs.”
The Inflation Reduction Act is a Foot in the Door for Containing Health Care Costs August 25, 2022 Perspective In this column for the JAMA Forum, KFF’s Larry Levitt explores the Medicare drug-price negotiation provisions and other significant drug-price changes in the Inflation Reduction Act and their potential to lead to further efforts to address health care costs.
Medicaid as a Potential New Third Rail of US Politics December 22, 2022 Perspective In this JAMA Forum column, KFF’s Larry Levitt examines Medicaid’s growing political importance and the potential double whammy that could hit state Medicaid programs next year with the end of the COVID-19 public health emergency and a possible simultaneous recession.
For All the ‘Grubergate’ Talk, Few Americans May Have Listened December 9, 2014 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the disconnect between Washington insiders and the public when it comes to attention paid to news stories like “Grubergate”.
Which Path for Health-Care Politics in 2015? January 6, 2015 Perspective This was published as a Wall Street Journal Think Tank column on January 6, 2015. Yogi Berra said that when you come to a fork in the road, take it. It will be that kind of year for health-care politics. The status quo is not an option. The key to which path…
High Health-Care Prices: More Talk Than Action January 12, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman explores how price is the major factor that distinguishes the cost of our health care system from those in other developed nations, yet most efforts in the U.S. to address health-care costs don’t focus on price much at all.